Well, his client (BYU) is suing Pfizer because they developed Celebrex and made $20 billion all the while cutting out the professor who discovered the COX-2 inhibiitor that made it all possible and with whom they had a contract. I've probably said too much.
4 comments:
I feel like going to "the dance" this Saturday, so I can introduce this hot line dance. Wanna go? We could dance with sweaty, short 14-year-olds.
Steve is suing Celebrex.
A. That was Neil. But we could all go. B. How come?
Well, his client (BYU) is suing Pfizer because they developed Celebrex and made $20 billion all the while cutting out the professor who discovered the COX-2 inhibiitor that made it all possible and with whom they had a contract. I've probably said too much.
I think that was the electric slide. Suspiciously familiar.
Post a Comment